CapsoVision, Inc. (CV) Gamma Exposure (GEX) & Greeks

Gamma exposure (GEX) analysis shows how options positioning creates dealer hedging pressure across strikes. Includes delta, vanna, charm, vomma, and vega exposure by strike price.

CapsoVision, Inc. (CV) operates in the Healthcare sector, specifically the Medical - Equipment & Services industry, with a market capitalization near $336.8M, listed on NASDAQ, employing roughly 90 people, carrying a beta of -2.62 to the broader market. Medical‑technology company developing advanced capsule endoscopy systems (CapsoCam Plus, CapsoCam Colon) and AI-enabled imaging platforms for gastrointestinal diagnostics Led by Kang-Huai Wang, public since 2001-09-03.

Greeks exposure analysis shows dealer hedging pressure across strike prices for all six Greeks. No recent options activity for CV as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how gamma exposure is reported and how to read the data →